Credit Ratings
Amgen Adds Celgene's Otezla to Bolster Pipeline at Pricey Valuation
Amgen is finally making an expected splash out of its cash pile, but questions are abounding about the cost paid for Celgene's Otezla.
Larry Culp's Cash Flow Comments Continue to Crush GE Stock
General Electric's CEO isn't inspiring much confidence.
Chart of the Day: Kraft Heinz Credit Outlook Is Troubling
KHC has a big problem on its balance sheet.
An Alternative to China Currency Management
Where China needs to defend the renminbi from falling too far.
What a Softening Corp. Bond Market Means
If money's already tight, long-term rates may have already peaked.
6 Top Tips for Income Investors in the Current Environment
From overweighting dividend stocks to avoiding high-yield bonds, this is how I'm playing things here.
Novice Trade: JNK High-Yield Bond ETF
A bearishly biased out-of-the-money long put 'shooter' expiring in January.
What Big Investors Are Truly Worried About Right Now
A road trip reveals some surprising answers.
5 Things To Know About Federal Reserve Chairman Jerome Powell
Watch our video and get to know your new Fed Chair.
European Ratings Agency Lists 3 Reasons to Worry About U.S. Tax Cuts
President Trump's tax cuts will push U.S. debt much higher, Scope Ratings warns.